GlassScriptPhysician profile
Brenden Cutter
NPI 1316434178
$9,159.97
in general payments reported to CMS, 2019-2025
10 companies · $1,943 in 2025
The $1,943 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2021: $1,200 · 2022: $179 · 2023: $89.35 · 2024: $5,160 · 2025: $1,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,354 · Travel and Lodging: $2,047 · Grant: $1,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,354.45 |
| Travel and Lodging | $2,046.87 |
| Grant | $1,791.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,230.46 | 2022-2025 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $2,488.06 | 2023-2024 | Avenir, Persona, G7 |
| Sequoia Surgical, INC. | $1,788.26 | 2019-2021 | |
| Depuy Synthes Sales INC. | $713.86 | 2024-2025 | Tfn-Advance, Na |
| Exactech, INC. | $278.44 | 2025 | |
| Onkos Surgical, INC. | $268.69 | 2024-2025 | Eleos Limb Salvage System |
| Smith+Nephew, INC. | $224.73 | 2025 | Journey II, Real Intelligence |
| Davol INC. | $119.94 | 2022 | |
| Polynovo North America LLC | $23.98 | 2025 | Novosorb Btm |
| Heron Therapeutics, INC. | $23.55 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenden Cutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.